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Abstract 
We identified nucleophosmin/B23 as a component of Template Activating Factor-III 
that stimulates the DNA replication from the adenovirus DNA complexed with viral basic 
core proteins.  Here, we have studied the functional interaction of B23 with viral core 
proteins.  We found that B23 interacts with viral basic core proteins, core protein V and 
precursor of core protein VII (pre-VII), in infected cells.  Biochemical analyses demonstrated 
that B23 suppresses formation of aggregates between DNA and core proteins and transfers 
pre-VII to DNA.  These results indicate that B23 functions as a chaperone in the viral 
chromatin assembly process in infected cells.  
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1.  Introduction 
The adenovirus (Ad) genome is a linear double-stranded DNA of approximately 36,000 
base pairs (bp) in length, and packed into the non-enveloped icosahedral particle.  The viral DNA 
is covalently linked with virally encoded terminal protein and condensed in the virion with viral 
core protein VII, core protein V, and polypeptide X, thus forming a chromatin-like structure, 
hereafter designated as Ad core [1-3].  Core protein VII, a 19 kDa protein with limited amino acid 
sequence similarity to histone H3 and a basic sperm-specific protein, is a major component of Ad 
core and tightly associated with  the Ad genome [4].  Core protein V associates loosely with Ad 
DNA and forms an outer shell around Ad core to link it with the capsid by binding with a dimer 
of polypeptide VI [5-7].  The infecting virus disassembles gradually in the cytoplasm after entry 
and penetration into host cells [8-11].  Core protein V is removed from Ad core immediately after 
entry into the nucleus, whereas core protein VII remains associated with the genome [12,13].  
Therefore, transcription of the early genes and the first round of viral DNA replication start using 
Ad DNA complexed with core protein VII as a template in infected cells.  During late stages of 
infection, the precursor of core protein VII (pre-VII) and core protein V package the newly 
replicated DNA into Ad core.  The detail molecular mechanism of disassembly and assembly of 
Ad core is not clear at present. 
We identified nucleophosmin/B23 as a component of Template Activating Factor (TAF)-
III that stimulates the DNA replication from Ad core [14].  Two splicing variants of B23, B23.1 
and B23.2, which differ only in their C-terminal regions, are expressed in a variety of growing 
cells.  Both B23.1 and B23.2 contain highly acidic domains, and the C-terminal region unique for 
B23.1 is essential for its RNA binding activity.  The nucleolar localization of B23 is disrupted 
upon Ad infection, and core protein V was shown to be responsible for re-localization of B23 
from the nucleolus to the whole cell [15].  Thus, it is possible that B23 is involved in the Ad life 
cycle.  However, the functional interaction between B23 and factors associated with Ad infection 
has not been described yet.  
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To explore the function of B23 in the Ad life cycle, we have studied the interaction 
between B23 and Ad core proteins.  We found that B23 interacts with both viral core protein V 
and pre-VII during late stages of infection.  Biochemical analyses demonstrated that B23 can 
induce dissociation of core proteins from DNA-core protein aggregates.   In addition, B23 was 
found to mediate formation of nucleoprotein complexes containing pre-VII.  Taken together, it is 
indicated that B23 functions as a chaperone for viral chromatin assembly. 
 
2.  Materials and methods 
 
2.1.  Plasmid construction and protein purification 
cDNA corresponding to the protein V was amplified by polymerase chain reaction (PCR) 
from the human adenovirus type 5 (HAdV-5) genomic DNA using a primer set, 5’-
AAGCTCGCATATGTCCAAGCGCAAAATCAAA-3’ and 5’-
AAGCTAAGGATCCTTAAACGATGCTGGGGTGGTA-3’.  The amplified PCR product was 
cloned into NdeI- and BamHI-digested pET14b (Novagen).  His-protein V expressed in the E.coli. 
strain BL21 codon plus RIL (STRATAGENE) was purified using His-bind resins (Novagen) 
according to the manufacturer’s instruction.  Core protein VII and pre-VII, and GST-tagged 
proteins were expressed and purified as previously described  [16,17]. 
 
2.2.  Immunoprecipitation assay 
HeLa cells were infected with HAdV-5 at multiplicity of infection (MOI) of 10.  At 24 h 
post infection (h.p.i.), cells (1X107) were collected and lysed on ice for 10 min in 1 ml of IP 
buffer (50 mM Tris-HCl  pH 7.9, 1 mM PMSF, 0.1% Triton X-100, and 1 mg/ml bovine serum 
albumin (BSA)) containing 150 mM NaCl followed by extensive sonication.  Cell extracts 
recovered as a supernatant fraction by centrifugation were mixed with anti-protein V (a generous 
 4
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
gift from Dr. W. C. Russel), anti-core protein VII [16], or anti-B23 (Zymed) antibodies, and 
incubated at 4°C for 3 h.  Then, Protein A Sepharose CL4B beads (10 μl of resin; Amersham 
Pharmacia) were added and further incubated for 1 h with gentle agitation.  Immunoprecipitated 
proteins were analyzed by SDS-PAGE followed by western blotting. 
 
2.3.  Electrophoretic mobility shift assay 
The 147 bp-long DNA fragment containing the 5S rRNA gene was amplified by PCR.  
DNA was first mixed with core proteins, and then increasing amounts of B23.1 were added, or 
core proteins pre-incubated with increasing amounts of B23 were mixed with DNA.  Both 
reactions were carried out at 37°C for 15 min in a buffer containing 40 mM Tris-HCl pH 7.9, 100 
mM NaCl, 0.1 mg/ml of BSA, and 10% glycerol and protein-DNA complexes were analyzed by 
6% PAGE in 0.5XTBE. 
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3.  Results and Discussion 1 
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3.1.  Interaction of B23 with core proteins V and VII in Ad infected cells 
To explore the function of B23 in the Ad life cycle, we first addressed whether B23 
interacts with viral core proteins by immunoprecipitation experiments.  HeLa cells were infected 
with HAdV-5, and cell lysates were prepared from cells at 24 h.p.i.  Immunoprecipitation assays 
were carried out with antibodies against B23, core protein V, and core protein VII.  Western blot 
analyses revealed that both core protein V and pre-VII were co-immunoprecipitated with B23 
(Fig. 1A, lane 6).  We also confirmed this interaction by immunoprecipitation assays using anti-
core protein VII and V antibodies (Fig. 1B, lanes 1-6 and lanes 7-12, respectively) followed by 
western blotting with anti-B23 antibody.  To further examine whether the interaction between 
B23 and basic core proteins was the consequence of artificial association between acidic and 
basic proteins, immunoprecipitation assays with antibodies against TAF-Iβ and B23 were carried 
out.  TAF-I is a highly acidic protein that was identified as a stimulatory factor for the Ad DNA 
replication [18].  As shown in Figs. 1A and B, both core protein V and pre-VII were co-
immunoprecipitated with B23, whereas only pre-VII was co-immunoprecipitated with TAF-I (Fig. 
1C).  The theoretical isoelectric point (pI) of TAF-I (4.12) is lower than that of B23.1 (4.64).  In 
addition, we previously found that small acidic protein pp32 with theoretical pI of 3.99 is not 
associated with pre-VII in infected cell extracts [19].   Therefore, these indicate that the 
interaction between B23 and viral core proteins is not explained simply by non-specific charge-
mediated interaction.  Although our anti-VII antibody recognizes both core protein VII and pre-
VII as shown in input extracts (Fig. 1A, lane 4), only pre-VII was found to be co-
immunoprecipitated with B23.  It was reported that immature virions termed sub-viral particles 
containing viral precursor proteins were assembled and form a distinct compartment in the 
nucleus before maturation of infectious virions [20].  In sub-viral particles, the viral precursor  
proteins including pre-VII are processed by a viral encoded protease [20].  Core protein VII 
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accumulated at the late stage of infection is present in the sub-viral particles, and thereby cellular 
proteins were not accessible.  In other words, cellular proteins associated with viral proteins 
outside sub-viral particles should be dissociated prior to formation of sub-viral particles.  Since 
pre-VII is processed by Ad protease after deposition on the viral genome and during packaging 
into sub-viral particles/virions, it is suggested that B23 plays a role in deposition of pre-VII to 
DNA. 
In order to test whether the interaction between B23 and core proteins in infected cells is 
direct, GST-pull down assays were carried out using purified recombinant proteins (Figs. 1D-F).  
The interaction between core protein V and GST proteins were detected by western blotting using 
anti-core protein V antibody.  GST-B23.1 and GST-B23.2, but not GST alone, pulled down core 
protein V (Fig. 1E).  Similarly, core protein VII and pre-VII were pulled-down with GST-B23.1 
(Fig. 1F, lanes 5 and 6).  Therefore, the interaction between B23 and viral core proteins is direct. 
 
3.2.  B23 is  co-fractionated with core protein V and pre-VII free of DNA 
During DNA replication in eukaryotic cells, newly replicated DNA is packaged into 
chromatin with histones synthesized concomitantly with DNA replication.  Chromatin assembly 
of newly replicated DNA is mediated by a class of proteins termed histone chaperones [21].  We 
showed that B23 functions as a histone chaperone [17].  To investigate a role of B23 in formation 
of  Ad DNA-core protein complexes, we examined whether B23 interacts with core proteins free 
of Ad DNA in infected cells.  At 24 h.p.i. when both core protein V and pre-VII are efficiently 
synthesized and their assembly to newly replicated Ad DNA has started, cell extracts were 
prepared and subjected to sucrose density gradient centrifugation (Fig. 2A).  In mock-infected cell 
extracts, B23 was broadly distributed with two peaks, one major peak in fractions 7-14 (peak I) 
and the other minor peak in fractions 18-21 (peak II).  Upon Ad infection, B23 in the peak I was 
slightly shifted toward the bottom and the amount of B23 recovered in the peak II increased 
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significantly.  The Ad DNA was examined by PCR with a primer set to amplify the E1A region 
[16].  In the peak II, core proteins and the viral genome were co-fractionated with B23.  Since 
pre-VII is processed during maturation of viral DNA-core protein complexes, the peak II is likely 
to contain the premature and mature Ad core.  Low but distinct amounts of core protein V and 
pre-VII were also found in the peak I in which the viral genome was not present (Fig. 2A, bottom 
panel).  B23 in the peak I was co-immunoprecipitated with core protein V and pre-VII (Fig. 2B, 
lanes 4 and 8).  These results suggest that B23 plays at least two distinct roles in viral chromatin 
assembly with core proteins either free of DNA or associated with the viral genome. 
 
3.3. Biochemical characterization of B23 as a chaperone for viral core proteins 
Sucrose density gradient assays demonstrated that B23 co-fractionated with viral core 
proteins free of DNA.  This complex is assumed to be an intermediate during transfer of core 
proteins to DNA.  This point was addressed by biochemical analyses using purified proteins.  
First, we tested the chaperone activity of B23 for core protein V (Figs. 3B and 3C).  Two sets of 
experiments were performed.  First, purified core protein V pre-incubated with DNA was mixed 
with increasing amounts of B23.1 (Fig. 3B).  Second, purified core protein V pre-incubated with 
increasing amounts of B23.1 was mixed with DNA (Fig. 3C).  DNA-protein complexes were 
analyzed by native PAGE.  When mixed directly, DNA-core protein V complexes were 
distributed as diffuse bands with a high intensity at the top of the gel, suggesting that core protein 
V binds DNA randomly (Fig. 3B, lane 3).  B23 shifted the bands toward the bottom of the gel and 
increased the amount of free DNA in a dose-dependent manner, indicating that B23 dissociates an 
excess amount of core protein V from DNA-core protein V complexes.  Similarly, when core 
protein V was pre-incubated with B23, B23 restricted the access of core protein V to DNA and 
suppressed the formation of random DNA-core protein V complexes in a dose-dependent manner 
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(Fig. 3C).  These results indicate that B23 associates with core protein V either complexed with 
or free of DNA to decrease the amount and level of aggregation. 
Next, we tested the ability of B23 as a chaperone for pre-VII (Figs. 3D and 3E).  When 
first mixed with DNA, pre-VII binds to DNA and forms a large aggregate that did not enter the 
gel under the condition employed (Fig. 3D, lanes 2 and 7).  However, B23 dissolved the 
aggregates containing DNA and pre-VII, and free DNA increased in a B23 dose-dependent 
manner.  Interestingly, when DNA-pre-VII aggregates were incubated with high doses of B23, an 
intermediate band appeared (white arrowhead).  Since B23 alone did not bind to DNA (Figs. 3B 
and 3C, lane 1), it is possible that some form of pre-VII-DNA complex was formed in the 
presence of high doses of B23.  When pre-VII was first pre-incubated with increasing amounts of 
B23, association of pre-VII with DNA was restricted and the amount of free DNA increased (Fig. 
3E).  Furthermore, the intermediate band appeared, suggesting that a fraction of pre-VII incubated 
with high doses of B23 was transferred to DNA.  We also found that B23ΔC3 that lacks the 
region essential for the association of B23 with pre-VII ([14] and data not shown) could not 
dissolve the aggregated DNA-pre-VII complex (Fig. 3F).  This indicates that the association 
between B23 and pre-VII is important for regulation of the structure of the DNA-pre-VII complex.  
To verify that B23 mediates deposition of pre-VII on DNA, [32P]-labeled 147 bp DNA alone, and 
pre-VII-B23 complexes incubated without or with [32P]-labeled DNA were subjected to glycerol 
density gradient (Fig. 4).  Pre-VII pre-incubated with B23 in the absence of DNA sedimented 
mainly in fraction 4 (Fig. 4A).  When pre-VII-B23 complex was incubated with DNA, the peak of 
pre-VII was slightly shifted toward the bottom and a minor population of pre-VII was recovered 
in the pellet fraction.  The intermediate shifted band was detected in fractions 4-6 on native 
PAGE.  To examine whether this band shift is due to the complex formation with pre-VII, each 
glycerol density gradient fraction was subjected to immunoprecipitation without or with anti-VII 
antibody.  As clearly shown in Fig. 4B, DNA was co-precipitated with pre-VII in fractions 2-6.  
Thus, we concluded that B23 can mediate the formation of the nucleoprotein complex containing 
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pre-VII.  These biochemical analyses altogether support an idea that B23 functions as a chaperone 
during viral chromatin assembly in infected cells. 
In this manuscript, we described a function of B23 in viral chromatin assembly at the late 
stage of infection.  In order to understand how B23 mediates the viral chromatin assembly, more 
detailed studies are needed.  However, based on our results we would propose that B23 is 
involved in viral chromatin assembly by two distinct mechanisms.   First, B23 may bind to newly 
synthesized core proteins and transfers them to DNA to assemble viral chromatin.  This is 
supported by the results that B23 is associated with core proteins in infected cell extracts (Figs. 1 
and 2) and B23 mediates transfer of core proteins to DNA (Figs. 3 and 4).  The other is that newly 
synthesized core proteins may bind with the viral genome first and B23 may regulate the amount 
of core proteins associated with viral genome (Figs. 3B and D).  To fully assemble the Ad core, it 
is important to clarify how core protein V and pre-VII are deposited on one DNA molecule.  In 
addition, viral core protein X/mu is also known to be associated with viral genome.  Thus, we 
have to take into consideration of this small core protein.  Recently, we have shown that TAF-I 
plays an important role in the early stages of adenovirus infection [19].  Since B23 was identified 
as an activity similar to that of TAF-I, it is also possible that B23 plays an important role in the 
early stage of infection.  The function of B23 at the early stage of Ad infection is under 
investigation. 
 
Acknowledgments:  We thank Dr. W. C. Russell for anti-protein V antibody.  This work was 
supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and 
Technology of Japan (M.O. and K.N.) and grants from the Bioarchitect Research Program 
(RIKEN) and the project of Tsukuba Advanced Research Alliance (K.N.). 
 
 10
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
References 
[1] Anderson, C.W., Young, M.E. and Flint, S.J. (1989) Virology 172, 506-12. 
[2] Chatterjee, P.K., Vayda, M.E. and Flint, S.J. (1986) J Mol Biol 188, 23-37. 
[3] Sung, M.T., Lischwe, M.A., Richards, J.C. and Hosokawa, K. (1977) J Biol Chem 
252, 4981-7. 
[4] Sung, Z.R. and Okimoto, R. (1983) Proc Natl Acad Sci U S A 80, 2661-2665. 
[5] Brown, D.T., Westphal, M., Burlingham, B.T., Winterhoff, U. and Doerfler, W. 
(1975) J Virol 16, 366-87. 
[6] Chatterjee, P.K., Vayda, M.E. and Flint, S.J. (1985) J Virol 55, 379-86. 
[7] Fedor, M.J. and Daniell, E. (1983) J Virol 47, 370-5. 
[8] Greber, U.F., Willetts, M., Webster, P. and Helenius, A. (1993) Cell 75, 477-86. 
[9] Greber, U.F., Webster, P., Weber, J. and Helenius, A. (1996) Embo J 15, 1766-77. 
[10] Martin-Fernandez, M., Longshaw, S.V., Kirby, I., Santis, G., Tobin, M.J., Clarke, 
D.T. and Jones, G.R. (2004) Biophys J 87, 1316-27. 
[11] Nakano, M.Y., Boucke, K., Suomalainen, M., Stidwill, R.P. and Greber, U.F. 
(2000) J Virol 74, 7085-95. 
[12] Matthews, D.A. and Russell, W.C. (1998) J Gen Virol 79 ( Pt 7), 1677-85. 
[13] Matthews, D.A. and Russell, W.C. (1998) J Gen Virol 79 ( Pt 7), 1671-5. 
[14] Okuwaki, M., Iwamatsu, A., Tsujimoto, M. and Nagata, K. (2001) J Mol Biol 311, 
41-55. 
[15] Matthews, D.A. (2001) J Virol 75, 1031-8. 
[16] Haruki, H., Gyurcsik, B., Okuwaki, M. and Nagata, K. (2003) FEBS Lett 555, 
521-7. 
[17] Okuwaki, M., Matsumoto, K., Tsujimoto, M. and Nagata, K. (2001) FEBS Lett 
506, 272-6. 
[18] Matsumoto, K., Nagata, K., Ui, M. and Hanaoka, F. (1993) J Biol Chem 268, 
10582-7. 
[19] Haruki, H., Okuwaki, M., Miyagishi, M., Taira, K. and Nagata, K. (2006) J Virol 
80, 794-801. 
[20] Weber, J. (1976) J Virol 17, 462-71. 
[21] Polo, S.E. and Almouzni, G. (2006) Curr Opin Genet Dev 16, 104-11. 
 11
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
Figure legends 
 
Fig. 1.  Interaction between B23 and core proteins in infected cells.  A, B: Immunoprecipitation 
from Ad-infected cell extracts.  Cell lysates prepared from mock- or Ad-infected HeLa cells were 
subjected to immunoprecipitation without or with anti-B23 antibody (A) or anti-core protein V 
and anti-core protein VII  antibodies (B).  B23 and core proteins VII and V were detected by 
western blotting.  Positions of the proteins were indicated at the right side of the panel.  Asteisks 
indicate the immunoglobin heavy chain.  C: Immunoprecipitation with anti-TAF-I and anti-B23 
antibodies.  Cell lysates prepared from mock (lane 1) and Ad-infected cells (lanes 2-4) were 
subjected to immunoprecipitation without (lane 3) or with anti-TAF-Iβ [19] (lanes 1 and 2) or 
anti-B23 (lane 4) antibody.  Proteins were separated on 10% SDS-PAGE followed by western 
blotting with anti-core protein V or VII antibodies (top and bottom panels, respectively).  D: 
Purified recombinant proteins.  Purified GST, GST-B23.1, GST-B23.2, and His-core protein V 
(lanes 1-4, respectively) were separated on a 10% SDS-PAGE and visualized by CBB staining.  
Lane M indicates molecular weight markers.  E: GST-pull down assays with core protein V.  GST, 
GST-B23.1, and GST-B23.2 (lanes 2-4, respectively) (1 μg each) were incubated with His-core 
protein V (1 μg) in IP buffer containing 200 mM NaCl and incubated at 4°C for 1 h.  Then 20 μl 
of glutathione Sepharose CL4B beads (Amersham Pharmacia) were added and further incubated 
for 1 h.  Proteins bound to glutathione-Sepharose beads were separated on a 12.5% SDS-PAGE 
and analyzed by western blotting with anti-core protein V antibody.  Purified core protein V (0.1 
μg, lane 1) was also shown.  F:  GST-pull down assays with core protein VII and pre-VII.  
Purified pre-VII (lanes 1, 3, and 5) and core protein VII (lanes 2, 4, and 6) (1 μg each) were 
mixed with either GST or GST-B23.1 (1 μg each) as in Fig. 1E. Proteins bound to Glutathione-
Sepharose beads were separated on a 12.5% SDS-PAGE and visualized by CBB staining.   Lane 
M indicates molecular weight markers.  Positions of GST, GST-B23.1, pre-VII and core protein 
VII were indicated at the left side of the panel. 
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Fig. 2.  Two forms of B23-core protein complexes.  A:  Sucrose density gradient.  HeLa cells 
were infected with HAdV-5 at MOI of 10.  At 24 h.p.i., mock- and Ad-infected HeLa cells were 
collected, suspended in hypotonic buffer (10 mM Hepes NaOH pH 7.9, 1.5 mM MgCl2, 10 mM 
KCl, and 0.5 mM DTT), and incubated on ice for 10 min.  Then, cells were disrupted by 
homogenization, and soluble cell extracts were recovered by centrifugation.  Extracts were 
dialyzed against 20 mM Tris HCl pH 7.9, 100 mM NaCl, 10% glycerol, 0.5 mM DTT, and 0.5 
mM PMSF and loaded on 2.2 ml of 10-60% sucrose density gradient.  Samples were centrifuged 
in TLS55 rotor (Beckman) at 50,000 rpm for 6.5 h.  Ten microliter of each fraction (100 μl) 
recovered from the top was separated on a 12.5% SDS-PAGE followed by western blotting using 
antibodies against B23, core proteins V, and VII.  The viral DNA was purified from each fraction 
and detected by PCR (bottom panel).  B:  Interaction of B23 with core protein V and pre-VII free 
of the Ad DNA.  Sucrose density gradient fractions 9-11 from mock- or Ad-infected extracts were 
subjected to immunoprecipitation with anti-core protein V (lanes 3 and 4) and anti-VII (lanes 7 
and 8) antibodies.  Immunoprecipitated proteins were separated on a 10% SDS-PAGE followed 
by western blotting with anti-B23 antibody.  The position of B23 is indicated by arrowheads.  
Asterisks indicate the immunoglobulin heavy chain. 
 
Fig. 3.  Function of B23 as a chaperone for viral core proteins.  A: Purified recombinant proteins.  
Purified pre-VII and His-B23.1 (lanes 1 and 2, respectively) were separated on a 12.5% SDS-
PAGE and visualized by staining with CBB.  B, C, D, E, F:  Roles of B23 in core protein-DNA 
complex formation.  Nucleoprotein complexes were resolved on a 6% PAGE in 0.5 X TBE and, 
DNA was visualized with SYBER-Gold staining.  (B) B23 dissociates excess amounts of core 
protein V from the DNA-core protein V complex.  Purified core protein V (50 ng) pre-incubated 
with 147 bp-long DNA (50 ng) was mixed without (lane 3) or with increasing amounts of B23.1 
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(50, 100, 200, and 400 ng for lanes 4-7, respectively) and further incubated.  DNA either with 
B23.1 (200 ng) or alone (lanes 1 and 2, respectively) was also loaded. (C) B23 suppresses the 
formation of random DNA-core protein V complex.  Purified core protein V pre-incubated 
without or with increasing amounts of B23.1 was mixed with DNA as in panel B. (D) B23 
dissociates pre-VII-DNA aggregates.  Purified pre-VII (50 ng for lanes 2-6 and 100 ng for lanes 
7-11) pre-incubated with DNA (50 ng) was mixed without (lanes 2 and 7) or with increasing 
amounts of B23.1 (50, 100, 200, and 400 ng for lanes 3-6 and 8-11, respectively) and further 
incubated.  Free DNA (lane 1) was also shown.  (E) B23 associates pre-VII to DNA.  Pre-VII pre-
incubated without or with increasing amounts of B23.1 was mixed with DNA as in panel D.  (F)  
B23ΔC cannot dissolve the aggregated pre-VII-DNA complex.  DNA (50 ng) and pre-VII (100 
ng) were pre-incubated, and increasing amounts of B23.1 (0, 50, 100, 200 ng for lanes 2-5) or 
B23ΔC (0, 50, 100, 200 ng for lanes 7-10) were added and further incubated.  Free DNA (lane 1 
and 6) was also shown.   
 
Fig. 4.  Transfer of pre-VII to DNA by B23.  A: Glycerol density gradient assay.  pre-VII (2 µg)-
B23 (25 µg) complexes in the absence or presence of [32P]-labeled 147 bp DNA (2 µg) were 
subjected to centrifugation at 50,000 rpm for 4 h in TLS 55 rotor on a 10-40% glycerol gradient, 
and fractions were recovered from the top.  After fractionation, remaining proteins in the pellet of 
the tube were suspended in 200 μl of buffer and recovered as a pellet fraction (P).  Proteins in 
each fraction were analyzed by western blotting, and [32P]-labeled DNA was analyzed by a 6% 
native PAGE.  B: Immunoprecipitation of glycerol density gradient fractions.  Each fraction from 
the pre-VII-B23-DNA complex and [32P]-labeled DNA alone was counted with scintillator (top 
panel), and each fraction was subjected to immunoprecipitation without or with anti-core protein 
VII antibody.  The radioactivity of immunoprecipitated DNA was analyzed with scintillator 
(bottom panel).  




